Athula Herath | Global Head of Real world Evidence Disease Epidemiology
Novartis

Athula Herath, Global Head of Real world Evidence Disease Epidemiology, Novartis

Athula Herath, PhD, MBCS, CITP, CEng
Athula Herath is the Global Head of Real World Evidence Epidemiology and affiliated with the Center of Excellence for Real World Evidence at Novartis. Prior to that, Athula worked for  10 years as Statistical Director for Medimmune/AstraZeneca. Athula joined pharmaceutical industry having spent 10 years tenure as a University Lecturer/Assistant Professor in academia in the U.K.
Athula is a data and statistical scientist specializing in  design and analysis of (uncommon) clinical, pragmatic and real world evidence/observational and biomarker studies, statistical modelling and simulation of biomarkers (genetics, genomics, proteomics, metabolomics) for disease onset, progression, clinical effect and outcome.

Appearances:



Pharma Pricing & Market Access USA Day 2 @ 10:40

From Astrology to Astronomy - The science demonstrating value of personalized medicines

  • Big Data Health Epidemiology: its progress and impacts on value
  • Population Centric Phenotypes and how we must consider them
  • Making inferences from Personal Genomes
Athula Herath, Global Head of Real world Evidence Disease Epidemiology, Novartis

back to speakers